Daniel Zabala, Joshua W. Cartwright, Douglas M. Roberts, Brian J. C. Law, Lijiang Song, Markiyan Samborskyy, Peter F. Leadlay, Jason Micklefield and Gregory L. Challis

J. Am. Chem. Soc., 2016, 138, 4342
DOI: 10.1021/jacs.6b01619

Identifying the Minimal Enzymes Required for Biosynthesis of Epoxyketone Proteasome Inhibitors

Joyce Liu, Xuejun Zhu and Wenjun Zhang

ChemBioChem, 2015, 16, 2585
DOI: 10.1002/cbic.201500496

Small molecules that target the ubiquitin system

Hai Qiu Wu, David Baker and Huib Ovaa

Biochemical Society Transactions, 2020, 48, 479
DOI: 10.1042/BST20190535

Viral entry and the ubiquitin‐proteasome system

Seth M. Schneider, Becky H. Lee and Anthony V. Nicola

Cellular Microbiology, 2021, 23
DOI: 10.1111/cmi.13276

A review on the treatment of multiple myeloma with small molecular agents in the past five years

Zhenzhen Zhang, Xin Liu, Liyun Zhao, Yaru Zhou, Jianyou Shi, Weini Chen and Jinqi Li

European Journal of Medicinal Chemistry, 2022, 229, 114053
DOI: 10.1016/j.ejmech.2021.114053

Asymmetric Reductive Amination of α-Keto Acids Using Ir-Based Hydrogen Transfer Catalysts: An Access to Unprotected Unnatural α-Amino Acids

Takaaki Yajima, Akito Katayama, Tsubasa Ito, Takuma Kawada, Kenya Yabushita, Toshihisa Yasuda, Takeshi Ohta, Takeaki Katayama, Noriyuki Utsumi, Yoshihito Kayaki and Shigeki Kuwata

Org. Lett., 2024, 26, 1426
DOI: 10.1021/acs.orglett.3c04378

Molecular tweaking by generative cheminformatics and ligand–protein structures for rational drug discovery

Ashwini K. Nangia

Bioorganic Chemistry, 2024, 153, 107920
DOI: 10.1016/j.bioorg.2024.107920

The Central Role of the Ubiquitin–Proteasome System in EBV-Mediated Oncogenesis

Yonggang Pei and Erle S. Robertson

Cancers, 2022, 14, 611
DOI: 10.3390/cancers14030611

The proteasome modulates endocytosis specifically in glomerular cells to promote kidney filtration

Wiebke Sachs, Lukas Blume, Desiree Loreth, Lisa Schebsdat, Favian Hatje, Sybille Koehler, Uta Wedekind, Marlies Sachs, Stephanie Zieliniski, Johannes Brand, Christian Conze, Bogdan I. Florea, Frank Heppner, Elke Krüger, Markus M. Rinschen, Oliver Kretz, Roland Thünauer and Catherine Meyer-Schwesinger

Nat Commun, 2024, 15
DOI: 10.1038/s41467-024-46273-0

Palladium‐Catalyzed Direct Functionalization of 2‐Aminobutanoic Acid Derivatives: Application of a Convenient and Versatile Auxiliary

Mengyang Fan and Dawei Ma

Angew Chem Int Ed, 2013, 52, 12152
DOI: 10.1002/anie.201306583

Noncanonical SQSTM1/p62-Nrf2 pathway activation mediates proteasome inhibitor resistance in multiple myeloma cells via redox, metabolic and translational reprogramming

Irene Riz, Teresa S. Hawley, Jeffrey W. Marsal and Robert G. Hawley

Oncotarget, 2016, 7, 66360
DOI: 10.18632/oncotarget.11960

Proteasome Inhibitors and Their Pharmacokinetics, Pharmacodynamics, and Metabolism

Jinhai Wang, Ying Fang, R. Andrea Fan and Christopher J. Kirk

IJMS, 2021, 22, 11595
DOI: 10.3390/ijms222111595

Polymer Micelle Formulations of Proteasome Inhibitor Carfilzomib for Improved Metabolic Stability and Anticancer Efficacy in Human Multiple Myeloma and Lung Cancer Cell Lines

Lin Ao, Derek Reichel, Di Hu, Hyunyoung Jeong, Kyung Bo Kim, Younsoo Bae and Wooin Lee

The Journal of Pharmacology and Experimental Therapeutics, 2015, 355, 168
DOI: 10.1124/jpet.115.226993

Synthesis and Characterisation of Bridged Morpholine Derivatives Fused to a Phenanthrene Ring System

H. Surya Prakash Rao and Satish Vijjapu

Journal of Chemical Research, 2017, 41, 210
DOI: 10.3184/174751917X14894997017577

Chronic Lymphocytic Leukemia: Exploiting Vulnerabilities with Targeted Agents

Joseph Maly and James S. Blachly

Curr Hematol Malig Rep, 2016, 11, 52
DOI: 10.1007/s11899-016-0299-0

Epoxides: methods of synthesis, reactivity, practical significance

V. L. Mamedova, G. Z. Khikmatova, D. E. Korshin, S. V K. Mamedova, E. L. Gavrilova and V. A O. Mamedov

RUSS CHEM REV, 2022, 91, RCR5049
DOI: 10.57634/RCR5049

Clogging the Ubiquitin-Proteasome Machinery with Marine Natural Products: Last Decade Update

Gerardo Della Sala, Francesca Agriesti, Carmela Mazzoccoli, Tiziana Tataranni, Valeria Costantino and Claudia Piccoli

Marine Drugs, 2018, 16, 467
DOI: 10.3390/md16120467

Developing natural product drugs: Supply problems and how they have been overcome

David J. Newman

Pharmacology & Therapeutics, 2016, 162, 1
DOI: 10.1016/j.pharmthera.2015.12.002

Discovery of CN0 as a novel proteolysis-targeting chimera (PROTAC) degrader of PARP1 that can activate the cGAS/STING immunity pathway combined with daunorubicin

Shanshan Lin, Guihui Tu, Zelei Yu, Qingna Jiang, Lingyu Zhang, Jingwen Liu, Quanyu Liu, Xiuwang Huang, Jianhua Xu, Youwen Lin, Yang Liu and Lixian Wu

Bioorganic & Medicinal Chemistry, 2022, 70, 116912
DOI: 10.1016/j.bmc.2022.116912

Functional Chromatography Reveals Three Natural Products that Target the Same Protein with Distinct Mechanisms of Action

Min Jin Kang, Tongde Wu, E. M. Kithsiri Wijeratne, Eric C. Lau, Damian J. Mason, Celestina Mesa, Joseph Tillotson, Donna D. Zhang, A. A. Leslie Gunatilaka, James J. La Clair and Eli Chapman

ChemBioChem, 2014, 15, 2125
DOI: 10.1002/cbic.201402258

High-throughput protein crystallography to empower natural product-based drug discovery

Raphael Meneghello, Joane K. Rustiguel, Evandro Ares de Araújo, Rafael de Felício, Arthur Zanetti N. Fernandes, Everton L. F. Ferreira, Juliana R. Gubiani, Agnes A. S. Takeda, Amanda Araujo, Caio C. de Lima Silva, Ariane F. Bertonha, Raquel P. M. Urano, Daniel M. Trindade, Thiago M. Cunha, Alisson C. Cardoso, Roberto G. S. Berlinck, Andrey F. Ziem Nascimento and Daniela B. B. Trivella

Acta Crystallogr F Struct Biol Commun, 2025, 81, 179
DOI: 10.1107/S2053230X25001542

Proteasome Inhibitors with Pyrazole Scaffolds from Structure-Based Virtual Screening

Zachary Miller, Keun-Sik Kim, Do-Min Lee, Vinod Kasam, Si Eun Baek, Kwang Hyun Lee, Yan-Yan Zhang, Lin Ao, Kimberly Carmony, Na-Ra Lee, Shou Zhou, Qingquan Zhao, Yujin Jang, Hyun-Young Jeong, Chang-Guo Zhan, Wooin Lee, Dong-Eun Kim and Kyung Bo Kim

J. Med. Chem., 2015, 58, 2036
DOI: 10.1021/jm501344n

Synthesis of Functionalized Epoxides by Copper-Catalyzed Alkylative Epoxidation of Allylic Alcohols with Alkyl Nitriles

Ala Bunescu, Qian Wang and Jieping Zhu

Org. Lett., 2015, 17, 1890
DOI: 10.1021/acs.orglett.5b00571

Bacteria as a treasure house of secondary metabolites with anticancer potential

Chakrabhavi Dhananjaya Mohan, Shobith Rangappa, S. Chandra Nayak, Ragi Jadimurthy, Lingzhi Wang, Gautam Sethi, Manoj Garg and Kanchugarakoppal S. Rangappa

Seminars in Cancer Biology, 2022, 86, 998
DOI: 10.1016/j.semcancer.2021.05.006

Selective degradation of splicing factor CAPERα by anticancer sulfonamides

Taisuke Uehara, Yukinori Minoshima, Koji Sagane, Naoko Hata Sugi, Kaoru Ogawa Mitsuhashi, Noboru Yamamoto, Hiroshi Kamiyama, Kentaro Takahashi, Yoshihiko Kotake, Mai Uesugi, Akira Yokoi, Atsushi Inoue, Taku Yoshida, Miyuki Mabuchi, Akito Tanaka and Takashi Owa

Nat Chem Biol, 2017, 13, 675
DOI: 10.1038/nchembio.2363

Patent Review of Manufacturing Routes to Oncology Drugs: Carfilzomib, Osimertinib, and Venetoclax

David L. Hughes

Org. Process Res. Dev., 2016, 20, 2028
DOI: 10.1021/acs.oprd.6b00374

BaxΔ2 sensitizes colorectal cancer cells to proteasome inhibitor-induced cell death

Adriana Mañas, Wenjing Chen, Adam Nelson, Qi Yao and Jialing Xiang

Biochemical and Biophysical Research Communications, 2018, 496, 18
DOI: 10.1016/j.bbrc.2017.12.156

Amycomicin is a potent and specific antibiotic discovered with a targeted interaction screen

Gleb Pishchany, Emily Mevers, Sula Ndousse-Fetter, Dennis J. Horvath, Camila R. Paludo, Eduardo A. Silva-Junior, Sergey Koren, Eric P. Skaar, Jon Clardy and Roberto Kolter

Proc. Natl. Acad. Sci. U.S.A., 2018, 115, 10124
DOI: 10.1073/pnas.1807613115

Synthesis and Evaluation of Macrocyclic Peptide Aldehydes as Potent and Selective Inhibitors of the 20S Proteasome

David L. Wilson, Isabel Meininger, Zack Strater, Stephanie Steiner, Frederick Tomlin, Julia Wu, Haya Jamali, Daniel Krappmann and Marion G. Götz

ACS Med. Chem. Lett., 2016, 7, 250
DOI: 10.1021/acsmedchemlett.5b00401

Malaria transmission-blocking Drugs: Implications and Future Perspectives

Ishan Wadi, Pargat Singh, Mahendra Nath, Anupkumar R Anvikar and Abhinav Sinha

Future Med. Chem., 2020, 12, 1071
DOI: 10.4155/fmc-2020-0026

Heterologous Expression of Epoxomicin in Escherichia coli

Sarah R. Messenger, David F. Ackerley and Mark J. Calcott

ACS Synth. Biol., 2024, 13, 2702
DOI: 10.1021/acssynbio.4c00430

Bortezomib in cancer therapy: Mechanisms, side effects, and future proteasome inhibitors

Olusola Sogbein, Pradipta Paul, Meenakshi Umar, Ali Chaari, Vecihi Batuman and Rohit Upadhyay

Life Sciences, 2024, 358, 123125
DOI: 10.1016/j.lfs.2024.123125

Design, Synthesis, and Biological Evaluation of Histone Deacetylase Inhibitors Derived from Erianin and Its Derivatives

Yawen Yang, Qingqing Liu, Xinyi Wang and Shaohua Gou

ChemMedChem, 2023, 18
DOI: 10.1002/cmdc.202300108

Approaches to mitigate the risk of serious adverse reactions in covalent drug design

Thomas A. Baillie

Expert Opinion on Drug Discovery, 2021, 16, 275
DOI: 10.1080/17460441.2021.1832079

The structural modification of natural products for novel drug discovery

Hong Yao, Junkai Liu, Shengtao Xu, Zheying Zhu and Jinyi Xu

Expert Opinion on Drug Discovery, 2017, 12, 121
DOI: 10.1080/17460441.2016.1272757

Targeting proteasomes in infectious organisms to combat disease

Betsaida Bibo‐Verdugo, Zhenze Jiang, Conor R. Caffrey and Anthony J. O'Donoghue

The FEBS Journal, 2017, 284, 1503
DOI: 10.1111/febs.14029

Immunoproteasome-selective and non-selective inhibitors: A promising approach for the treatment of multiple myeloma

Roberta Ettari, Maria Zappalà, Silvana Grasso, Caterina Musolino, Vanessa Innao and Alessandro Allegra

Pharmacology & Therapeutics, 2018, 182, 176
DOI: 10.1016/j.pharmthera.2017.09.001

Medicinal Potential of Heterocyclic Compounds from Diverse Natural Sources for the Management of Cancer

Manjinder Singh, Pratibha Sharma, Pankaj Kumar Singh, Thakur Gurjeet Singh and Balraj Saini

MRMC, 2020, 20, 942
DOI: 10.2174/1389557520666200212104742

Chemistry of Covalent Drugs: Chemical Reactions with Endogenous Proteins in Live Cells

Naoya Shindo and Akio Ojida

J. Synth. Org. Chem. Jpn., 2024, 82, 50
DOI: 10.5059/yukigoseikyokaishi.82.50

Cryptic enzymatic assembly of peptides armed with β-lactone warheads

Guangcai Xu, Daniele Torri, Sebastian Cuesta-Hoyos, Deepanjan Panda, Luke R. L. Yates, Rémi Zallot, Kehan Bian, Dongxu Jia, Andreea I. Iorgu, Colin Levy, Sarah A. Shepherd and Jason Micklefield

Nat Chem Biol, 2024, 20, 1371
DOI: 10.1038/s41589-024-01657-7

Synthetic approaches to the 2012 new drugs

Hong X. Ding, Carolyn A. Leverett, Robert E. Kyne, Kevin K.-C. Liu, Subas M. Sakya, Andrew C. Flick and Christopher J. O’Donnell

Bioorganic & Medicinal Chemistry, 2014, 22, 2005
DOI: 10.1016/j.bmc.2014.02.017

Validation of Babesia proteasome as a drug target

Marie Jalovecka, David Hartmann, Yukiko Miyamoto, Lars Eckmann, Ondrej Hajdusek, Anthony J. O'Donoghue and Daniel Sojka

International Journal for Parasitology: Drugs and Drug Resistance, 2018, 8, 394
DOI: 10.1016/j.ijpddr.2018.08.001

Synthesis and biological evaluation of nannocystin analogues toward understanding the binding role of the (2R,3S)-Epoxide in nannocystin A

Yunfeng Tian, Xiaolong Xu, Yahui Ding, Xin Hao, Yanju Bai, Yang Tang, Xuemei Zhang, Qiuying Li, Zhantao Yang, Weicheng Zhang and Yue Chen

European Journal of Medicinal Chemistry, 2018, 150, 626
DOI: 10.1016/j.ejmech.2018.03.012

Asymmetric Epoxidation of Enones Promoted by Dinuclear Magnesium Catalyst

Joanna A. Jaszczewska‐Adamczak and Jacek Mlynarski

Adv Synth Catal, 2021, 363, 4247
DOI: 10.1002/adsc.202100482

Chemoenzymatic Synthesis of Novel Cytotoxic Epoxyketones Using the Eponemycin Biosynthetic Enzyme EpnF

Broderick C. Corless, Raphael Geißen, Nicholas A. Prescott, Yael David, David A. Scheinberg and Derek S. Tan

ACS Chem. Biol., 2023, 18, 1360
DOI: 10.1021/acschembio.3c00080

Ubiquitin proteasome system (UPS): a crucial determinant of the epigenetic landscape in cancer

Srija Roy and Mrinal K. Ghosh

Epigenomics, 2025, 17, 625
DOI: 10.1080/17501911.2025.2501524

Carfilzomib-Loaded Ternary Polypeptide Nanoparticles Stabilized by Polycationic Complexation

Preye Agbana, Ji Eun Park, Piotr Rychahou, Kyung-Bo Kim and Younsoo Bae

Journal of Pharmaceutical Sciences, 2024, 113, 711
DOI: 10.1016/j.xphs.2023.08.026

Small‐Molecule Control of Intracellular Protein Levels through Modulation of the Ubiquitin Proteasome System

Dennis L. Buckley and Craig M. Crews

Angew Chem Int Ed, 2014, 53, 2312
DOI: 10.1002/anie.201307761

WRN inhibition leads to its chromatin-associated degradation via the PIAS4-RNF4-p97/VCP axis

Fernando Rodríguez Pérez, Dean Natwick, Lauren Schiff, David McSwiggen, Alec Heckert, Melina Huey, Huntly Morrison, Mandy Loo, Rafael G. Miranda, John Filbin, Jose Ortega, Kayla Van Buren, Danny Murnock, Arnold Tao, Renee Butler, Kylie Cheng, William Tarvestad, Zhengjian Zhang, Eric Gonzalez, Rand M. Miller, Marcus Kelly, Yangzhong Tang, Jaclyn Ho, Daniel Anderson, Charlene Bashore and Stephen Basham

Nat Commun, 2024, 15
DOI: 10.1038/s41467-024-50178-3

Enhanced Glioblastoma Targeting Ability of Carfilzomib Enabled by a DA7R-Modified Lipid Nanodisk

Mingfei Zhang, Linwei Lu, Man Ying, Huitong Ruan, Xiaoyi Wang, Huan Wang, Zhilan Chai, Songli Wang, Changyou Zhan, Jun Pan and Weiyue Lu

Mol. Pharmaceutics, 2018, 15, 2437
DOI: 10.1021/acs.molpharmaceut.8b00270

Bioinspired manganese complexes catalyzed epoxidation for the synthesis of the epoxyketone fragment of carfilzomib

Bin Qiu, Chungu Xia and Wei Sun

Chinese Chemical Letters, 2019, 30, 698
DOI: 10.1016/j.cclet.2018.10.023

From Oxiranes to Oligomers: Architectures of U.S. FDA Approved Pharmaceuticals Containing Oxygen Heterocycles

Michael D. Delost, David T. Smith, Benton J. Anderson and Jon T. Njardarson

J. Med. Chem., 2018, 61, 10996
DOI: 10.1021/acs.jmedchem.8b00876

Chemoreactive 2,5-Diketopiperazines from a Penicillium sp., Structure Revision of Reported Analogues and Proposed Facile Transformation Pathways

Quan T. Khong, Emily A. Smith, Karen L. Wendt, Masoumeh Dalilian, Ekaterina I. Goncharova, Isaac Brownell, Robert H. Cichewicz, Curtis J. Henrich, John A. Beutler, Barry R. O’Keefe and Lin Du

J. Nat. Prod., 2024, 87, 1826
DOI: 10.1021/acs.jnatprod.4c00478

Continuous Process Improvement in the Manufacture of Carfilzomib, Part 1: Process Understanding and Improvements in the Commercial Route to Prepare the Epoxyketone Warhead

Peter K. Dornan, Travis Anthoine, Matthew G. Beaver, Guilong Charles Cheng, Dawn E. Cohen, Sheng Cui, William E. Lake, Neil F. Langille, Susan P. Lucas, Jenil Patel, William Powazinik, Scott W. Roberts, Chris Scardino, John L. Tucker, Simone Spada, Alicia Zeng and Shawn D. Walker

Org. Process Res. Dev., 2020, 24, 481
DOI: 10.1021/acs.oprd.0c00051

Vimentin Phosphorylation Underlies Myofibroblast Sensitivity to Withaferin A In Vitro and during Corneal Fibrosis

Paola Bargagna-Mohan, Ling Lei, Alexis Thompson, Camille Shaw, Kousuke Kasahara, Masaki Inagaki, Royce Mohan and Alexander V. Ljubimov

PLoS ONE, 2015, 10, e0133399
DOI: 10.1371/journal.pone.0133399

From Discovery to Bedside: Targeting the Ubiquitin System

Ingrid E. Wertz and Xiaojing Wang

Cell Chemical Biology, 2019, 26, 156
DOI: 10.1016/j.chembiol.2018.10.022

Proteases and Their Modulators in Cancer Therapy: Challenges and Opportunities

Rao Song, Wenliang Qiao, Jun He, Jiasheng Huang, Youfu Luo and Tao Yang

J. Med. Chem., 2021, 64, 2851
DOI: 10.1021/acs.jmedchem.0c01640

Heterologous Production of Glidobactins/Luminmycins in Escherichia coli Nissle Containing the Glidobactin Biosynthetic Gene Cluster from Burkholderia DSM7029

Xiaoying Bian, Fan Huang, Hailong Wang, Thorsten Klefisch, Rolf Müller and Youming Zhang

ChemBioChem, 2014, 15, 2221
DOI: 10.1002/cbic.201402199

Ethylbenzene Hydroperoxide: An efficient oxidizing agent for diastereoselective synthesis of Spiroepoxy oxindoles

Praveen K. Valmiki, Mohan Banyangala, Sunil Varughese and Sasidhar B. Somappa

Tetrahedron Letters, 2022, 108, 154126
DOI: 10.1016/j.tetlet.2022.154126

Chemical Tagging of Bioactive Amides by Cooperative Catalysis: Applications in the Syntheses of Drug Conjugates

Cunyuan Zhao, Yuankai Wang, Quan Pham, Changhang Dai, Abhishek Chatterjee and Masayuki Wasa

J. Am. Chem. Soc., 2023, 145, 14233
DOI: 10.1021/jacs.3c00169

Residue-Selective Inhibitors Discovery via Covalent DNA-Encoded Chemical Libraries with Diverse Warheads

Xinyuan Wu, Jiayi Pan, Rufeng Fan, Yiwei Zhang, Chao Wang, Guoliang Wang, Jiaxiang Liu, Mengqing Cui, Jinfeng Yue, Rui Jin, Zhiqiang Duan, Mingyue Zheng, Lianghe Mei, Lu Zhou, Minjia Tan, Jing Ai and Xiaojie Lu

J. Am. Chem. Soc., 2025, 147, 15469
DOI: 10.1021/jacs.5c01712

Chemoselective P(NMe2)3-Mediated Reductive Epoxidation between Two Different Carbonyl Electrophiles: Synthesis of Highly Functionalized Unsymmetrical Epoxides

Rong Zhou, Honghui Zhang, Jialin Liu, Rongfang Liu, Wen-Chao Gao, Yan Qiao and Ruifeng Li

J. Org. Chem., 2018, 83, 8272
DOI: 10.1021/acs.joc.8b00995

Carfilzomib induces G2/M cell cycle arrest in human endometrial cancer cells via upregulation of p21Waf1/Cip1 and p27Kip1

Yuanyuan Zhou, Ke Wang, Shuai Zhen, Ruili Wang and Wenjuan Luo

Taiwanese Journal of Obstetrics and Gynecology, 2016, 55, 847
DOI: 10.1016/j.tjog.2016.09.003

The roles of protein expression in synaptic plasticity and memory consolidation

Tali Rosenberg, Shunit Gal-Ben-Ari, Daniela C. Dieterich, Michael R. Kreutz, Noam E. Ziv, Eckart D. Gundelfinger and Kobi Rosenblum

Front. Mol. Neurosci., 2014, 7
DOI: 10.3389/fnmol.2014.00086

Carfilzomib shows therapeutic potential for reduction of liver fibrosis by targeting hepatic stellate cell activation

Ayana Fujiwara, Keisuke Takemura, Anna Tanaka, Misaki Matsumoto, Masato Katsuyama, Takeshi Okanoue, Kanji Yamaguchi, Yoshito Itoh, Kazumi Iwata, Kikuko Amagase and Atsushi Umemura

Sci Rep, 2024, 14
DOI: 10.1038/s41598-024-70296-8

Carfilzomib Is Not an Appropriate Payload of Antibody-Drug Conjugates Due to Rapid Inactivation by Lysosomal Enzymes

Yong Ma, Josefa Dela Cruz-Chuh, S. Cyrus Khojasteh, Peter S. Dragovich, Thomas H. Pillow and Donglu Zhang

Drug Metabolism and Disposition, 2019, 47, 884
DOI: 10.1124/dmd.119.086595

Peptide‐Based Proteasome Inhibitors in Anticancer Drug Design

Nicola Micale, Kety Scarbaci, Valeria Troiano, Roberta Ettari, Silvana Grasso and Maria Zappalà

Medicinal Research Reviews, 2014, 34, 1001
DOI: 10.1002/med.21312

Polymer micelle formulation for the proteasome inhibitor drug carfilzomib: Anticancer efficacy and pharmacokinetic studies in mice

Ji Eun Park, Se-Eun Chun, Derek Reichel, Jee Sun Min, Su-Chan Lee, Songhee Han, Gongmi Ryoo, Yunseok Oh, Shin-Hyung Park, Heon-Min Ryu, Kyung Bo Kim, Ho-Young Lee, Soo Kyung Bae, Younsoo Bae, Wooin Lee and Aamir Ahmad

PLoS ONE, 2017, 12, e0173247
DOI: 10.1371/journal.pone.0173247

Feeling Nature’s PAINS: Natural Products, Natural Product Drugs, and Pan Assay Interference Compounds (PAINS)

Jonathan B. Baell

J. Nat. Prod., 2016, 79, 616
DOI: 10.1021/acs.jnatprod.5b00947

Drug Syntheses Beyond the Rule of 5

Mohit Tyagi, Fabio Begnini, Vasanthanathan Poongavanam, Bradley C. Doak and Jan Kihlberg

Chemistry A European J, 2020, 26, 49
DOI: 10.1002/chem.201902716

Identification of Covalent Ligands – from Single Targets to Whole Proteome

Chau Ngo, Arunika Ekanayake and Chao Zhang

Israel Journal of Chemistry, 2023, 63
DOI: 10.1002/ijch.202200105

Phase I dose escalation trial of the novel proteasome inhibitor carfilzomib in patients with relapsed chronic lymphocytic leukemia and small lymphocytic lymphoma

Farrukh T. Awan, Joseph M. Flynn, Jeffrey A. Jones, Leslie A. Andritsos, Kami J. Maddocks, Ellen J. Sass, Margaret S. Lucas, Weihong Chase, Sharon Waymer, Yonghua Ling, Yao Jiang, Mitch A. Phelps, John C. Byrd, David M. Lucas and Jennifer A. Woyach

Leukemia & Lymphoma, 2015, 56, 2834
DOI: 10.3109/10428194.2015.1014368

Proteasome Inhibitors: Harnessing Proteostasis to Combat Disease

David J. Sherman and Jing Li

Molecules, 2020, 25, 671
DOI: 10.3390/molecules25030671

Unusual Amino Acids in Medicinal Chemistry

Mark A. T. Blaskovich

J. Med. Chem., 2016, 59, 10807
DOI: 10.1021/acs.jmedchem.6b00319

David and Goliath: chemical perturbation of eukaryotes by bacteria

Louis K Ho and Justin R Nodwell

Journal of Industrial Microbiology and Biotechnology, 2016, 43, 233
DOI: 10.1007/s10295-015-1686-6

Erianin inhibits the oncogenic properties of hepatocellular carcinoma via inducing DNA damage and aberrant mitosis

Heng Dong, Menglan Wang, Cunjie Chang, Mengqing Sun, Fan Yang, Lina Li, Mengqing Feng, Lele Zhang, Qian Li, Yannan Zhu, Yiting Qiao, Tian Xie and Jianxiang Chen

Biochemical Pharmacology, 2020, 182, 114266
DOI: 10.1016/j.bcp.2020.114266

Proteolysis-Targeting Chimeras as Therapeutics and Tools for Biological Discovery

George M. Burslem and Craig M. Crews

Cell, 2020, 181, 102
DOI: 10.1016/j.cell.2019.11.031

Small-Molecule Screens: A Gateway to Cancer Therapeutic Agents with Case Studies of Food and Drug Administration–Approved Drugs

Nathan P. Coussens, John C. Braisted, Tyler Peryea, G. Sitta Sittampalam, Anton Simeonov and Matthew D. Hall

Pharmacological Reviews, 2017, 69, 479
DOI: 10.1124/pr.117.013755

Epoxide Syntheses and Ring-Opening Reactions in Drug Development

Fotini Moschona, Ioanna Savvopoulou, Maria Tsitopoulou, Despoina Tataraki and Gerasimos Rassias

Catalysts, 2020, 10, 1117
DOI: 10.3390/catal10101117

Investigation of the Compatibility between Warheads and Peptidomimetic Sequences of Protease Inhibitors—A Comprehensive Reactivity and Selectivity Study

Patrick Müller, Mergim Meta, Jan Laurenz Meidner, Marvin Schwickert, Jessica Meyr, Kevin Schwickert, Christian Kersten, Collin Zimmer, Stefan Josef Hammerschmidt, Ariane Frey, Albin Lahu, Sergio de la Hoz-Rodríguez, Laura Agost-Beltrán, Santiago Rodríguez, Kira Diemer, Wilhelm Neumann, Florenci V. Gonzàlez, Bernd Engels and Tanja Schirmeister

IJMS, 2023, 24, 7226
DOI: 10.3390/ijms24087226

The past decade of Genentech experience in elucidation of novel reaction mechanisms in drug metabolism

Cyrus Khojasteh, Jasleen K. Sodhi, Jason Halladay and Donglu Zhang

Med Chem Res, 2023, 32, 2016
DOI: 10.1007/s00044-023-03128-5

Copper(II) Complexes with Isomeric Morpholine-Substituted 2-Formylpyridine Thiosemicarbazone Hybrids as Potential Anticancer Drugs Inhibiting Both Ribonucleotide Reductase and Tubulin Polymerization: The Morpholine Position Matters

Miljan N. M. Milunovic, Katerina Ohui, Iuliana Besleaga, Tatsiana V. Petrasheuskaya, Orsolya Dömötör, Éva A. Enyedy, Denisa Darvasiova, Peter Rapta, Zuzana Barbieriková, Daniel Vegh, Szilárd Tóth, Judit Tóth, Nóra Kucsma, Gergely Szakács, Ana Popović-Bijelić, Ayesha Zafar, Jóhannes Reynisson, Anatoly D. Shutalev, Ruoli Bai, Ernest Hamel and Vladimir B. Arion

J. Med. Chem., 2024, 67, 9069
DOI: 10.1021/acs.jmedchem.4c00259

Late‐Stage Modification of Oligopeptides by Nickel‐Catalyzed Stereoselective Radical Addition to Dehydroalanine

Xiaoxu Qi, Subramanian Jambu, Yining Ji, Kevin M. Belyk, Nihar R. Panigrahi, Paramjit S. Arora, Neil A. Strotman and Tianning Diao

Angew Chem Int Ed, 2022, 61
DOI: 10.1002/anie.202213315

Steuerung der intrazellulären Proteinmenge durch niedermolekulare Modulatoren des Ubiquitin‐Proteasom‐Systems

Dennis L. Buckley and Craig M. Crews

Angewandte Chemie, 2014, 126, 2344
DOI: 10.1002/ange.201307761

Cytotoxic Spiroepoxide Lactone and Its Putative Biosynthetic Precursor from Goniobranchus Splendidus

Louise C. Forster, Gregory K. Pierens, Andrew M. White, Karen L. Cheney, Pradeep Dewapriya, Robert J. Capon and Mary J. Garson

ACS Omega, 2017, 2, 2672
DOI: 10.1021/acsomega.7b00641

Proteasome inhibitors as anticancer agents

Giorgia Gazzaroli, Andrea Angeli, Arianna Giacomini and Roberto Ronca

Expert Opinion on Therapeutic Patents, 2023, 33, 775
DOI: 10.1080/13543776.2023.2272648

Synthesis of Mimics of Pramanicin from Pyroglutamic Acid and Their Antibacterial Activity

Song Wei Benjamin Tan, Christina L. L. Chai, Mark G. Moloney and Amber L. Thompson

J. Org. Chem., 2015, 80, 2661
DOI: 10.1021/jo502810b

Carfilzomib alleviated osteoporosis by targeting PSME1/2 to activate Wnt/β-catenin signaling

Fan Zhang, Shokouh Attarilar, Kegong Xie, Chao Han, Qingyang liang, Ke Huang, Changgong Lan, Chong Wang, Chengliang Yang, Liqiang Wang, Masoud Mozafari, Kai Li, Jia Liu and Yujin Tang

Molecular and Cellular Endocrinology, 2022, 540, 111520
DOI: 10.1016/j.mce.2021.111520

Pluronic F127/carfilzomib-based nanomicelles as promising nanocarriers: synthesis, characterization, biological, and in silico evaluations

Abbas Rahdar, Mohammad Reza Hajinezhad, Saman Sargazi, Mahmood Barani, Pouya Karimi, Brenda Velasco, Pablo Taboada, Sadanand Pandey, Zakaria Bameri and Sadegh Zarei

Journal of Molecular Liquids, 2022, 346, 118271
DOI: 10.1016/j.molliq.2021.118271

The Search for Inhibitors of the Ubiquitin-proteasome System from Natural Sources by Cell-based Screening in Reporter-expressing Cells

Yuki Hitora and Sachiko Tsukamoto

J. Synth. Org. Chem. Jpn., 2023, 81, 1073
DOI: 10.5059/yukigoseikyokaishi.81.1073

Discovery, Structure Elucidation, and Biological Characterization of Nannocystin A, a Macrocyclic Myxobacterial Metabolite with Potent Antiproliferative Properties

Holger Hoffmann, Herbert Kogler, Winfried Heyse, Hans Matter, Michael Caspers, Dietmar Schummer, Christine Klemke‐Jahn, Armin Bauer, Geraldine Penarier, Laurent Debussche and Mark Brönstrup

Angewandte Chemie, 2015, 127, 10283
DOI: 10.1002/ange.201411377

Harnessing bacterial metabolites for enhanced cancer chemotherapy: unveiling unique therapeutic potentials

Aroni Chatterjee, Rajni Khan, Triparna Mukherjee, Preity Pragnya Sahoo, Laxmi Narayan Tiwari, Basant Narain Singh, Rashmi Kumari, Anisha Kumari, Ankit Rai and Shashikant Ray

Arch Microbiol, 2024, 206
DOI: 10.1007/s00203-024-04179-x

Targeting BCR-ABL1 in Chronic Myeloid Leukemia by PROTAC-Mediated Targeted Protein Degradation

George M. Burslem, Anna Reister Schultz, Daniel P. Bondeson, Christopher A. Eide, Samantha L. Savage Stevens, Brian J. Druker and Craig M. Crews

Cancer Research, 2019, 79, 4744
DOI: 10.1158/0008-5472.CAN-19-1236

Palladium‐Catalyzed Direct Functionalization of 2‐Aminobutanoic Acid Derivatives: Application of a Convenient and Versatile Auxiliary

Mengyang Fan and Dawei Ma

Angewandte Chemie, 2013, 125, 12374
DOI: 10.1002/ange.201306583

Natural Products as Sources of New Drugs from 1981 to 2014

David J. Newman and Gordon M. Cragg

J. Nat. Prod., 2016, 79, 629
DOI: 10.1021/acs.jnatprod.5b01055

The role of carfilzomib in relapsed/refractory multiple myeloma

Andrew J. Yee

Therapeutic Advances in Hematology, 2021, 12
DOI: 10.1177/20406207211019612

Epoxides: Developability as active pharmaceutical ingredients and biochemical probes

Baljit Kaur and Palwinder Singh

Bioorganic Chemistry, 2022, 125, 105862
DOI: 10.1016/j.bioorg.2022.105862

VPS28 regulates triglyceride synthesis via ubiquitination in bovine mammary epithelial cells

Lily Liu, Jinhai Wang, Xianrui Zheng and Qin Zhang

Sci Rep, 2024, 14
DOI: 10.1038/s41598-024-82774-0

Discovery, Structure Elucidation, and Biological Characterization of Nannocystin A, a Macrocyclic Myxobacterial Metabolite with Potent Antiproliferative Properties

Holger Hoffmann, Herbert Kogler, Winfried Heyse, Hans Matter, Michael Caspers, Dietmar Schummer, Christine Klemke‐Jahn, Armin Bauer, Geraldine Penarier, Laurent Debussche and Mark Brönstrup

Angew Chem Int Ed, 2015, 54, 10145
DOI: 10.1002/anie.201411377

Opportunities and guidelines for discovery of orally absorbed drugs in beyond rule of 5 space

Vasanthanathan Poongavanam, Bradley C. Doak and Jan Kihlberg

Current Opinion in Chemical Biology, 2018, 44, 23
DOI: 10.1016/j.cbpa.2018.05.010

Bioconjugate Platform for Iterative Backbone N-Methylation of Peptides

Yiwu Zheng, Chayanid Ongpipattanakul and Satish K. Nair

ACS Catal., 2022, 12, 14006
DOI: 10.1021/acscatal.2c04681

Sustainable healing: Natural compounds facilitating the future cancer treatment

M．Amin Mir and Bimal Krishna Banik

World Development Sustainability, 2025, 6, 100215
DOI: 10.1016/j.wds.2025.100215

Combating Malaria: Targeting the Ubiquitin-Proteasome System to Conquer Drug Resistance

Bazgha Sanaullah, Nguyen Van Truong, Tuyet-Kha Nguyen and Eun-Taek Han

TropicalMed, 2025, 10, 94
DOI: 10.3390/tropicalmed10040094

Non‐lethal proteasome inhibition activates pro‐tumorigenic pathways in multiple myeloma cells

Aikaterini Skorda, Aimilia D. Sklirou, Theodore Sakellaropoulos, Despoina D. Gianniou, Efstathios Kastritis, Evangelos Terpos, Ourania E. Tsitsilonis, Bogdan I. Florea, Herman S. Overkleeft, Meletios A. Dimopoulos, Leonidas G. Alexopoulos and Ioannis P. Trougakos

J Cellular Molecular Medi, 2019, 23, 8010
DOI: 10.1111/jcmm.14653

The proteasome as a druggable target with multiple therapeutic potentialities: Cutting and non-cutting edges

G.R. Tundo, D. Sbardella, A.M. Santoro, A. Coletta, F. Oddone, G. Grasso, D. Milardi, P.M. Lacal, S. Marini, R. Purrello, G. Graziani and M. Coletta

Pharmacology & Therapeutics, 2020, 213, 107579
DOI: 10.1016/j.pharmthera.2020.107579

The proteasome as a target to combat malaria: hits and misses

Karthik Mosur Krishnan and Kim C. Williamson

Translational Research, 2018, 198, 40
DOI: 10.1016/j.trsl.2018.04.007

Late‐Stage Modification of Oligopeptides by Nickel‐Catalyzed Stereoselective Radical Addition to Dehydroalanine

Xiaoxu Qi, Subramanian Jambu, Yining Ji, Kevin M. Belyk, Nihar R. Panigrahi, Paramjit S. Arora, Neil A. Strotman and Tianning Diao

Angewandte Chemie, 2022, 134
DOI: 10.1002/ange.202213315

Pharmacokinetic aspects of the clinically used proteasome inhibitor drugs and efforts toward nanoparticulate delivery systems

Seungbin Kwon, Kyung Bo Kim, Yoon Yeo and Wooin Lee

J. Pharm. Investig., 2021, 51, 483
DOI: 10.1007/s40005-021-00532-0

NLRP3 Ubiquitination—A New Approach to Target NLRP3 Inflammasome Activation

Mahbuba Akther, Md Ezazul Haque, Jooho Park, Tae-Bong Kang and Kwang-Ho Lee

IJMS, 2021, 22, 8780
DOI: 10.3390/ijms22168780

Amino acidic scaffolds bearing unnatural side chains: An old idea generates new and versatile tools for the life sciences

Andrea Stevenazzi, Mattia Marchini, Giovanni Sandrone, Barbara Vergani and Maria Lattanzio

Bioorganic & Medicinal Chemistry Letters, 2014, 24, 5349
DOI: 10.1016/j.bmcl.2014.10.016

Small-Molecule Modulation of Protein Homeostasis

George M. Burslem and Craig M. Crews

Chem. Rev., 2017, 117, 11269
DOI: 10.1021/acs.chemrev.7b00077

Exploration of the carmaphycins as payloads in antibody drug conjugate anticancer agents

Jehad Almaliti, Bailey Miller, Halina Pietraszkiewicz, Evgenia Glukhov, C. Benjamin Naman, Toni Kline, Jeffrey Hanson, Xiaofan Li, Sihong Zhou, Frederick A. Valeriote and William H. Gerwick

European Journal of Medicinal Chemistry, 2019, 161, 416
DOI: 10.1016/j.ejmech.2018.10.024

Advances in covalent drug discovery

Lydia Boike, Nathaniel J. Henning and Daniel K. Nomura

Nat Rev Drug Discov, 2022, 21, 881
DOI: 10.1038/s41573-022-00542-z

Regulating the Master Regulator: Controlling Ubiquitination by Thinking Outside the Active Site

Stacey-Lynn Paiva, Sara R. da Silva, Elvin D. de Araujo and Patrick T. Gunning

J. Med. Chem., 2018, 61, 405
DOI: 10.1021/acs.jmedchem.6b01346